QSPainRelief is an international, collaborative research project, funded by the European Commission, that brings together 10 partner institutions from 5 European countries and the United States of America.
The 5-year-long project started in January 2020 and uses an innovative quantitative systems pharmacology (QSP) pain relief approach to develop effective combinational treatment of chronic pain in individual patients. In our half-yearly newsletter, we inform you of scientific advances in the project, new team members, events, and other relevant news. The research consortium is spearheaded by Prof. Dr. Liesbeth de Lange from Leiden University and includes experts in clinical pain care, preclinical and molecular research, neuroscience, in silico modelling, data management, and ethics.
The ultimate goal of our efforts is to maximise pain relief for the individual patient, and to significantly improve the overall quality of life for chronic pain patients. To do so, we are aiming for personalised, mechanism-based novel combinations of existing medicines. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848068.
The newsletter reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains.
Click here to read QSPainRelief’s first newsletter!
Pain Alliance Europe (PAE) is part of the Scientific and Ethical Advisory Board of the QSPainRelief project.
